Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1193736
Author(s) Craig, Vanessa J; Cogliatti, Sergio B; Imig, Jochen; Renner, Christoph; Neuenschwander, Stefan; Rehrauer, Hubert; Schlapbach, Ralph; Dirnhofer, Stephan; Tzankov, Alexander; Müller, Anne
Author(s) at UniBasel Tzankov, Alexandar
Dirnhofer, Stephan
Cogliatti, Sergio Bruno
Year 2011
Title Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
Journal Blood
Volume 117
Number 23
Pages / Article-Number 6227-36
Abstract Gastric marginal zone B-cell lymphoma of MALT type (MALT lymphoma) arises in the context of chronic inflammation induced by the bacterial pathogen Helicobacter pylori. Although generally considered an indolent disease, MALT lymphoma may transform to gastric diffuse large B-cell lymphoma (gDLBCL) through mechanisms that remain poorly understood. By comparing microRNA expression profiles of gastric MALT lymphoma and gDLBCL, we have identified a signature of 27 deregulated microRNAs(miRNAs) that share the characteristic of being transcriptionally repressed by Myc. Myc overexpression was consequently detected in 80% of gDLBCL but only 20% of MALT lymphomas spotted on a tissue microarray. A highly similar signature of Myc-repressed miRNAs was further detected in nodal DLBCL. Small interfering RNA-mediated knock-down of Myc blocked proliferation of DLBCL cell lines. Of the Myc-repressed miRNAs down-regulated in malignant lymphoma, miR-34a showed the strongest antiproliferative properties when overexpressed in DLBCL cells. We could further attribute miR-34a's tumor-suppressive effects to deregulation of its target FoxP1. FoxP1 overexpression was detected in gDLBCL but not in gastric MALT lymphoma; FoxP1 knock-down efficiently blocked DLBCL proliferation. In conclusion, our results elucidate a novel Myc- and FoxP1-dependent pathway of malignant transformation and suggest miR-34a replacement therapy as a promising strategy in lymphoma treatment.
Publisher American Society of Hematology
ISSN/ISBN 1528-0020
edoc-URL http://edoc.unibas.ch/dok/A6003975
Full Text on edoc No
Digital Object Identifier DOI 10.1182/blood-2010-10-312231
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/21460242
ISI-Number WOS:000291438000024
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.328 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
14/05/2024